BEI
CLGN icon

Benjamin Edwards Inc’s CollPlant Biotechnologies CLGN Stock Holding History

Benjamin Edwards Inc’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,381
Closed -$112K – 1107
2024
Q3 		$112K Buy
+2,381
New +$117K ﹤0.01% 1074

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Benjamin Edwards Inc's CLGN Position: Q4 2024 in Review

Benjamin Edwards Inc sold out of CollPlant Biotechnologies (CLGN) in Q4 2024, closing a stake of 2,381 shares — an estimated $112K sold.

Benjamin Edwards Inc first reported a position in CLGN in Q3 2024 and held it in 1 quarter. The position peaked at $112K in Q3 2024. 13 funds tracked by Wall St. Rank hold CLGN as of Q4 2024.

  • Benjamin Edwards Inc reported no remaining CollPlant Biotechnologies position as of Q4 2024 after selling out during the quarter.
  • Benjamin Edwards Inc sold 2,381 CollPlant Biotechnologies shares in Q4 2024, an estimated $112K.
  • Benjamin Edwards Inc first reported a position in CollPlant Biotechnologies in Q3 2024 and held it in 1 quarter.
  • Benjamin Edwards Inc's CollPlant Biotechnologies position peaked at $112K in Q3 2024.
  • 13 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q4 2024.

Based on Benjamin Edwards Inc's 13F filing for Q4 2024, filed 14 Feb 2025.